首页> 外文期刊>Scientific reports. >Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge
【24h】

Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge

机译:来自鞭毛蛋白缺乏沙门氏菌的外膜囊泡肠道肠毒鼠诱导杂交反应性免疫力,并提供对异源沙门氏菌攻击的交叉保护

获取原文
       

摘要

Outer membrane vesicles (OMVs) isolated from Salmonella Typhimurium are potentially useful for developing subunit vaccines because of high immunogenicity and protective efficacy. However, flagella might remain in OMV pellets following OMV purification, resulting in non-essential immune responses and counteraction of bacterial protective immune responses when developing a vaccine against infection of multiple serotypes Salmonella. In this study, a flagellin-deficient S. Typhimurium mutant was constructed. Lipopolysaccharide profiles, protein profiles and cryo-electron microscopy revealed that there were no significant differences between the wild-type and mutant OMVs, with the exception of a large amount of flagellin in the wild-type OMVs. Neither the wild-type OMVs nor the non-flagellin OMVs were toxic to macrophages. Mice immunized with the non-flagellin OMVs produced high concentrations of IgG. The non-flagellin OMVs elicited strong mucosal antibody responses in mice when administered via the intranasal route in addition to provoking higher cross-reactive immune responses against OMPs isolated from S. Choleraesuis and S. Enteritidis. Both intranasal and intraperitoneal immunization with the non-flagellin OMVs provided efficient protection against heterologous S. Choleraesuis and S. Enteritidis challenge. Our results indicate that the flagellin-deficient OMVs may represent a new vaccine platform that could be exploited to facilitate the production of a broadly protective vaccine.
机译:由于高免疫原性和保护性功效,从沙门氏菌伤寒毒蕈中分离的外膜囊泡(OMV)可能用于开发亚基疫苗。然而,鞭毛可能在OMV纯化后留在omv颗粒中,导致在发育疫苗的疫苗免受多种血清型沙门氏菌感染时的非必要免疫反应和对抗的反应。在这项研究中,构建了鞭毛蛋白缺陷的伤寒伤寒突变体。脂多糖曲线,蛋白质谱和冷冻电子显微镜表明,野生型和突变体OMV之间没有显着差异,除了野生型OMV中的大量鞭毛蛋白。野生型omvs也不是非鞭毛素omv对巨噬细胞有毒。用非鞭毛蛋白OMV免疫的小鼠产生了高浓度的IgG。在通过鼻内途径施用外,非鞭毛蛋白OMVs在小鼠中引发了小鼠的强粘膜抗体反应,除了针对从S.Choleraesuis和S. EnterItidis中分离的OMPS进行冈孔的高反应性免疫应答。鼻内和腹膜内免疫的含有非鞭毛蛋白OMV的免疫既提供了对异源核糖菌的有效保护。我们的结果表明,鞭毛蛋白缺陷型OMV可以代表一种新的疫苗平台,可以利用来促进促进广泛保护疫苗。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号